Trial intelligence / Profile preview

Atorvastatin in patients with multiple sclerosis

IRCT2015071323184N1Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of atorvastatin in multiple sclerosis (MS), sponsored by Arak University of Medical Sciences. Started Mar 2011; status: completed.

02

Drugs

atorvastatin
03

Conditions

multiple sclerosis (MS)

Beyond the preview

Go deeper on IRCT2015071323184N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015071323184N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call